They observed pervasive transcriptional downregulation of adenocarcinoma lineage markers (NAPSA, NKX2-1, SFTA2, and SFTA3), validated orthogonally via multiplex immunohistochemistry. This evidence concerns the gene SFTA2 and adenocarcinoma.